 Connection
Sarah Parker to Staphylococcal Infections
This is a "connection" page, showing publications Sarah Parker has written about Staphylococcal Infections.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.004 |
|
|
|
-
Haynes AS, Maples H, Parker S. Time for a Change: Considering Vancomycin Alternatives for Pediatric Methicillin-Resistant Staphylococcus aureus Bacteremia. J Pediatric Infect Dis Soc. 2023 May 31; 12(5):308-318.
Score: 0.570
-
Searns JB, Hall M, Birkholz M, Downes KJ, Hubbell BB, Kern-Goldberger AS, Markham JL, Newland JG, Rolsma SL, Wang ME, O'Leary ST, Dominguez SR, Parker SK, Kronman MP. Accuracy of pathogen diagnostic codes for acute hematogenous musculoskeletal infections in children. J Hosp Med. 2025 Aug; 20(8):853-857.
Score: 0.159
-
Haynes AS, Prinzi A, Silveira LJ, Parker SK, Lampe JN, Kavanaugh JS, Horswill AR, Fish D. Cefadroxil Comparable to Cephalexin: Minimum Inhibitory Concentrations among Methicillin-Susceptible Staphylococcus aureus Isolates from Pediatric Musculoskeletal Infections. Microbiol Spectr. 2022 08 31; 10(4):e0103922.
Score: 0.134
-
Spaulding AB, Thurm C, Courter JD, Banerjee R, Gerber JS, Newland JG, Parker SK, Brogan TV, Kronman MP, Shah SS, Smith MJ, Patel SJ, Lee BR, Hersh AL. Epidemiology of Staphylococcus aureus infections in patients admitted to freestanding pediatric hospitals, 2009-2016. Infect Control Hosp Epidemiol. 2018 12; 39(12):1487-1490.
Score: 0.104
-
Haynes AS, Wei Z, Anderson P, Scheetz MH, Parker SK, Fish DN. Cefadroxil and cephalexin pharmacokinetics and pharmacodynamics in children with musculoskeletal infections. Antimicrob Agents Chemother. 2024 05 02; 68(5):e0018224.
Score: 0.038
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|